Explore how Japan—and global regulators—are advancing toward eCTD v4.0 adoption. Learn key timelines (PMDA from April 2026, EMA from Q3 2026, FDA draft by late 2025), strategic advantages, and readiness strategies for streamlined, metadata-driven regulatory submissions. https://japan.freyrsolutions.com/blogs/japan-and-the-global-ectd-v4-0-wave-timelines-trends-readiness